- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2373-8057
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients ; volume:7 ; number:1 ; day:4 ; month:1 ; year:2021 ; pages:1-12 ; date:12.2021
npj Parkinson's Disease ; 7, Heft 1 (4.1.2021), 1-12, 12.2021
- Creator
-
Anderson, Faith L.
Herrmann, Katharine M. von
Andrew, Angeline S.
Kuras, Yuliya I.
Young, Alison L.
Scherzer, Clemens R.
Hickey, William F.
Lee, Stephen L.
Havrda, Matthew C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-020-00147-6
- URN
-
urn:nbn:de:101:1-2021020121222572299127
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Anderson, Faith L.
- Herrmann, Katharine M. von
- Andrew, Angeline S.
- Kuras, Yuliya I.
- Young, Alison L.
- Scherzer, Clemens R.
- Hickey, William F.
- Lee, Stephen L.
- Havrda, Matthew C.
- SpringerLink (Online service)
Other Objects (12)
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Lack of genetic evidence for NLRP3 inflammasome involvement in Parkinson’s disease pathogenesis
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease
LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson’s disease
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Plasma VCAM1 levels correlate with disease severity in Parkinson’s disease
Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson’s disease
The association between indicators of health and housing in people with Parkinson’s disease
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease
Plasma arylsulfatase A levels are associated with cognitive function in Parkinson’s disease
Parkinson
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Lack of genetic evidence for NLRP3 inflammasome involvement in Parkinson’s disease pathogenesis
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease
LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson’s disease
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Plasma VCAM1 levels correlate with disease severity in Parkinson’s disease
Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson’s disease
The association between indicators of health and housing in people with Parkinson’s disease
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease
Plasma arylsulfatase A levels are associated with cognitive function in Parkinson’s disease
Parkinson
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Lack of genetic evidence for NLRP3 inflammasome involvement in Parkinson’s disease pathogenesis
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease
LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson’s disease
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Plasma VCAM1 levels correlate with disease severity in Parkinson’s disease
Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson’s disease
The association between indicators of health and housing in people with Parkinson’s disease
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease
Plasma arylsulfatase A levels are associated with cognitive function in Parkinson’s disease